Back to Treatments

Treatment

Latiglutenase (ALV003 / BL-7010) (Investigational)

1

Conditions

8

Trials

1,500

Participants

80%

Average Safety

Condition Evidence

Celiac Disease

8 trials · 1,500 participants

55% effectiveness · 80% safety

Latiglutenase (ALV003 / BL-7010) (Investigational) | DFDA